Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
3 March 2016
Header
Header image
News

News

EFPIA Statement on Brexit
24 February 2016

EFPIA believes that the UK’s continued membership of the EU is in the best interests of the pharmaceutical industry in the UK and across Europe. As [...] Read more

From our blog

From our blog

EMA’s PRIME can help speed delivery of new medicines to patients (Guest Blog)
03 March 2016 by Sue Forda

Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted the Priority Medicines (PRIME) scheme. PRIME is a welcome step towards connecting healthcare decision-makers to expedite patient access to new medicines – but what sets it apart from other mechanisms with similar aims? 

Read more

From our blog

IMI: a Major Contribution to the Fight Against Rare Disease (Guest Blog)
03 March 2016 by Carlo Incerti, Salah-Dine Chibout

Some 7,000 rare diseases exist worldwide, each of which might affect as few as hundreds of individuals worldwide. While some of them are cancers, others impact the body’s metabolism, the immune system and the central nervous system – yet most of them lack an effective diagnostic tool or, very importantly, a therapy.

Read more

Events calendar

Events Calendar

EFPIA Annual Conference 2016
On 15/06/2016 (Radisson Hotel, Brussels)

This year's EFPIA Annual Conference will take place on 15 June 2016, at the Radisson Hotel in Brussels. The event will examine the challenges faced by healthcare systems in Europe, the exciting science that will play a key role in meeting these challenges and the long-term sustainability of healthcare delivery. An interactive exhibition will be set up to provide attendees with further insight into EFPIA’s current initiatives, which aim at facilitating a pan-European dialogue on the importance of shifting towards a model of outcomes-driven healthcare.
 
The final programme can be accessed here
 
Read more

Events Calendar

Inaugural Conference of the European Institute for Innovation through Health Data (i~HD)
On 10/03/2016 (Paris, France)

This Inaugural Conference will mark the parallel launch of a novel European platform to support multi-centre clinical research. This operational platform, the result of the European project EHR4CR (Electronic Health Records for Clinical Research), can connect securely to the data within multiple hospital EHR systems and clinical data warehouses across Europe, to enable a trial sponsor to predict the number of eligible patients for a candidate clinical trial protocol, to assess its feasibility and to locate the most relevant hospital sites.

The role of i~HD, as a not-for-profit Institute, is to provide independent governance oversight of such services now, and as these expand to connect with many more hospitals across Europe. The conference will present this platform and its pharma-led adoption programme, and detail the i~HD governance services that reflect state-of-the-art in the trustworthy re-use of health data for research. You will also learn about Europe's largest "big data" project in health: EMIF (European Medical Information Framework). The views of patients on the benefits of reusing their data for research will be presented by Mary Baker, past President of the European Brain Council, one of our keynote speakers.

For more information, please click here

Read more

Events Calendar

DIA 28th Annual EuroMeeting 2016
From 06/04/2016 to 08/04/2016 (Hamburg, Germany)

In a world in which new therapies are being developed at a phenomenal rate, is innovation always the answer?

The DIA EuroMeeting is the premier platform on which to exchange ideas with thought leaders on key challenges and opportunities facing health care product development professionals. 

By attending EuroMeeting 2016, you will discuss issues while building relationships with your regulatory, industry and academia counterparts who are guiding the trends.

DOWNLOAD PROGRAMME

Read more

Events Calendar

Biovision World Life Science Forum
From 13/04/2016 to 14/04/2016 (Lyon, France)

The Biovision World Life Science Forum is fostering a unique approach to meet and connect with, as well as collaborate between international decision-makers from the academic, civil society, policy-making and private sectors, whether industrial or investors.

Biovision 2016's pattern is dedicated to strengthening Action & Interaction for Innovation with:

  • A prospective part with a main theme on "Global health and Prevention" and specific paths (Medicine & Humanities, Vaccines, Cancer Prevention and Digitalised Patients) with workshops, plenary sessions and calls for action.
  • Catalyser & Investor parts with reinforced and segmented sourcing allowing more specific expertise for the evaluation and follow up of the projects, including financing.
Read more

Events Calendar

GetReal Webinar on "Effectiveness research: navigating real world solutions"
On 23/03/2016

This webinar, “Effectiveness research: navigating real world approaches”, will provide an opportunity for participants to receive the latest updates on key outputs from the IMI GetReal project. The IMI GetReal project has focused on exploring how best to tackle effectiveness research before marketing authorisation.

Read more

What we are reading

What we are reading

Antibiotics are becoming less effective, and new drugs are urgently needed
03 March 2016 (POLITICO)

Urgent action is needed to reduce overuse of antibiotics and to enable the development of new drugs, panelists told a POLITICO conference on Wednesday, February 17.

Read more

What we are reading

Health Programme 2014-2020: Commission adopts Work Programme for 2016
03 March 2016 (European Commission)

In the context of the EU’s Health Programme 2014-2020, the Commission has today adopted the Work Programme for 2016

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail